InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,562.12
(
-0.47%
)
US TECH 100
19,182.40
(
-0.46%
)
Dow Jones
40,926.23
(
-0.66%
)
Brent Oil
84.48
(
-0.01%
)
Bitcoin
63,802.43
(
-0.44%
)
Post# of 252636
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: ghmm post# 121061

Wednesday, 06/08/2011 12:59:37 PM

Wednesday, June 08, 2011 12:59:37 PM

Post# of 252636
UTHR/FREEDOM-M trial for oral Treprostinil

Tyvaso also showed improvement in placebo-adjusted median 6 minute walk distance of approximately 20 meters and missed its secondary endpoints in TRIUMPH study, but was approved.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up